IRINOTECAN WITH BIWEEKLY, LOW DOSE LEUCOVORIN AND BOLUS AND CONTINUOUS INFUSION 5-FLUOROURACIL (MODIFIED FOLFIRI) AS FIRST LINE THERAPY FOR PATIENTS WITH RECURRENT OR METASTATIC GASTRIC CANCER

被引：0
|
作者：
Oh, S. Y. [1 ]
Kim, B. G. [1 ]
Kwon, H. [1 ]
Lee, S. [1 ]
Lee, D. M. [1 ]
Jang, J. S. [1 ]
Kim, M. C. [1 ]
Kim, S. [1 ]
Kim, H. [1 ]
机构：
[1] Dong A Univ, Coll Med, Pusan, South Korea
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [1] A Phase II Study of Irinotecan With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFIRI) as First Line Therapy For Patients With Recurrent or Metastatic Gastric Cancer
    Kim, Byung Geun
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Lee, Suee
    Lee, Dong Mee
    Kim, Seong-Geun
    Kim, Do-Kyong
    Jang, Jin Seok
    Kim, Min Chan
    Kim, Sung-Hyun
    Kim, Hyo-Jin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 246 - 250
  • [2] Oxaloplatin with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX 4) as salvage therapy for patients with advanced gastric cancer
    Kwon, H. C.
    Kim, S. H.
    Kim, J. S.
    Kim, H. J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 219 - 219
  • [3] A phase II study of irinotecan with bi-weekly, low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (Modified FOLFIRI) as salvage therapy for patients with advanced or metastatic gastric cancer
    Kim, Seong-Geun
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Lee, Suee
    Kim, Jung Hwan
    Kim, Sung-Hyun
    Kim, Hyo-Jin
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (10) : 744 - 749
  • [4] A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Seo, Bong-Gun
    Kim, Sung-Hyun
    Kim, Jae-Seok
    Kim, Hyo-Jin
    ACTA ONCOLOGICA, 2007, 46 (03) : 336 - 341
  • [5] Phase I Study of Combination Therapy with Irinotecan, Leucovorin, and Bolus and Continuous-infusion 5-Fluorouracil (FOLFIRI) for Advanced Colorectal Cancer in Japanese Patients
    Sasaki, Yusuke
    Hamaguchi, Tetsuya
    Arai, Tatsuhiro
    Goto, Ayumu
    Ura, Takashi
    Muro, Kei
    Yamada, Yasuhide
    Shirao, Kuniaki
    Shimada, Yasuhiro
    ANTICANCER RESEARCH, 2014, 34 (04) : 2029 - 2034
  • [6] CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer
    André, T
    Louvet, C
    Maindrault-Goebel, F
    Couteau, C
    Mabro, M
    Lotz, JP
    Gilles-Amar, V
    Krulik, M
    Carola, E
    Izrael, V
    de Gramont, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (09) : 1343 - 1347
  • [7] Bolus infusion of cisplatin, 5-fluorouracil, and leucovorin as alternative first-line therapy for advanced gastric cancer.
    Coelho, Rafael Correa
    Abreu, Pedro Duarte
    Monteiro, Mariana Ribeiro
    Stramosk, Ana Paula
    Gil, Roberto Almeida
    Siqueira, Mariana
    Vilhena Pereira, Bruno dos Santos
    Duque, Cristiano Guedes
    Palladino, Alexandre de Mendonca
    Graudenz, Marcia Silveira
    Andrade, Carlos J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Irinotecan, leucovorin and 5-fluorouracil (modified FOLFIRI) as salvage chemotherapy for frail or elderly patients with advanced gastric cancer
    Kim, Jung Han
    Kim, Hyeong Su
    Han, A. Rum
    Moh, In Ho
    Chung, Doo Cheol
    Choi, Dae Ro
    Jang, Hyun Joo
    Kim, Jin Bae
    Yang, Dae Hyun
    Lee, Soon Il
    Zang, Dae Young
    ONCOLOGY LETTERS, 2012, 4 (04) : 751 - 754
  • [9] Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study
    Ting Deng
    Le Zhang
    Xiao-jian Liu
    Jian-ming Xu
    Yu-xian Bai
    Yan Wang
    Yu Han
    Yu-hong Li
    Yi Ba
    Medical Oncology, 2013, 30
  • [10] Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study
    Deng, Ting
    Zhang, Le
    Liu, Xiao-jian
    Xu, Jian-ming
    Bai, Yu-xian
    Wang, Yan
    Han, Yu
    Li, Yu-hong
    Ba, Yi
    MEDICAL ONCOLOGY, 2013, 30 (04)
12345